Lipopeptide CPE4 (TFA)
Lipopeptide CPE4 TFA is a PEG-modified peptide E4 [ (EIAALEK) 4]. Lipopeptide CPE4 TFA is capable of coiled-coil formation when attached to liposomes. Lipopeptide CPE4 TFA triggers membrane fusion between liposomes and living cells with concomitant efficient cytosolic delivery of a variety of compounds such as fluorescent dyes Propidium Iodide (PI) (HY-D0815) and TO-PRO-3 iodide (HY-117070), and Doxorubicin (DOX) (HY-15142A) . Lipopeptide CPE4 TFA can be used for drug delivery research[1].
Product Specifications
UNSPSC
12352209
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Purity
98.69
Smiles
Molecular Formula
C177H303N35O51.xC2HF3O2
Molecular Weight
3737.50 (free base)
References & Citations
[1]Yang J, et al. Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS Cent Sci. 2016 Sep 28;2 (9) :621-630.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items